Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02610309 · ClinicalTrials.gov registry record · NA

Family-based Crisis Intervention With Suicidal Adolescents in the ED

A NA study of Suicide, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
143
Enrollment target
1
Study location

NCT02610309: Completed NA study of Suicide, sponsored by Boston Children's Hospital.

NCT02610309 is a NA study of Suicide that has completed, run by Boston Children's Hospital. The registered enrollment target is 143 participants, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02610309, a NA study of Suicide, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
143 participants
Enrollment target
1
Study location

Study Summary

The Family Based Crisis Intervention (FBCI) is an emergency psychiatry intervention designed to sufficiently stabilize suicidal adolescents within a single ED visit so that they may return home safely with their families. This study is a randomized clinical trial of FBCI v. TAU in an urban Emergency Department.

Primary Outcome

The primary outcome measure is disposition (psychiatric hospitalization vs. less restrictive level of care) after receiving the FBCI intervention or TAU. Psychiatric hospitalization was reassessed at 1 day, 1 week and 1 month intervals after randomization.

Conditions Studied

Interventions

  • BEHAVIORAL Family-Based Crisis Intervention

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2012-01
Est. Completion 2014-05
Phase NA
Boston Children's Hospital

462 total trials

What the finished NCT02610309 record still lists

NCT02610309 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Family-Based Crisis Intervention is the first listed.

NCT02610309 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02610309 about?

NCT02610309 is a clinical study titled "Family-based Crisis Intervention With Suicidal Adolescents in the ED". The Family Based Crisis Intervention (FBCI) is an emergency psychiatry intervention designed to sufficiently stabilize suicidal adolescents within a single ED visit so that they may return home safely with their families. This study is a randomized clinical trial of FBCI v. TAU in an urban Emergency...

What is the current status of trial NCT02610309?

This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2012-01. Estimated completion is 2014-05.

What conditions does trial NCT02610309 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT02610309?

The interventions under investigation include: Family-Based Crisis Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02610309?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02610309 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02610309's enrollment target sits among peer trials

143 40th of 92 higher than 53 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02610309, the US trial registry maintained by the National Library of Medicine. NCT02610309 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.